Industry: Pharmaceuticals, Biotechnology
RenaMed Biologics, Inc. is a privately-held biotechnology company focused on developing therapies for life-saving intervention in critical medical conditions, especially those associated with inflammation, organ failure and compromised kidney function. The Company has developed a new therapeutic approach, Renal Bio-Replacement Therapy (RBT), and has completed two Phase 2 clinical trials of RBT for the treatment for Acute Renal Failure (ARF). In addition, the company is actively seeking to license new programs that complement its focus on life-saving medical therapeutics. RenaMed’s has significant Intellectual Property in renal cell technology from both internal developments and an extensive set of exclusive licenses from the University of ( www.renamed.com )
RenaMed Biologics , Inc.
6 Court Drive
Lincoln, Rhode Island 02865
USA
Tel: (401) 333-3789
Fax: (401) 333-3774